CHENG Jing, LV Tang-feng. A Rising Star, Birabresib (MK-8628) Targets Advanced Solid Tumors Including NUT Carcinoma by Inhibiting Bromodomain and Extraterminal Proteins[J]. Journal of Evidence-Based Medicine, 2024, 24(5): 272-275. DOI: 10.12019/j.issn.1671-5144.202410047
|
Citation:
|
CHENG Jing, LV Tang-feng. A Rising Star, Birabresib (MK-8628) Targets Advanced Solid Tumors Including NUT Carcinoma by Inhibiting Bromodomain and Extraterminal Proteins[J]. Journal of Evidence-Based Medicine, 2024, 24(5): 272-275. DOI: 10.12019/j.issn.1671-5144.202410047
|
CHENG Jing, LV Tang-feng. A Rising Star, Birabresib (MK-8628) Targets Advanced Solid Tumors Including NUT Carcinoma by Inhibiting Bromodomain and Extraterminal Proteins[J]. Journal of Evidence-Based Medicine, 2024, 24(5): 272-275. DOI: 10.12019/j.issn.1671-5144.202410047
|
Citation:
|
CHENG Jing, LV Tang-feng. A Rising Star, Birabresib (MK-8628) Targets Advanced Solid Tumors Including NUT Carcinoma by Inhibiting Bromodomain and Extraterminal Proteins[J]. Journal of Evidence-Based Medicine, 2024, 24(5): 272-275. DOI: 10.12019/j.issn.1671-5144.202410047
|
DownLoad: